HomeINDV • LON
add
Indivior PLC
Nakaraang pagsara
GBX 699.50
Sakop ng araw
GBX 714.00 - GBX 773.50
Sakop ng taon
GBX 548.71 - GBX 1,770.00
Market cap
938.85M GBP
Average na Volume
381.79K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 298.00M | 1.71% |
Gastos sa pagpapatakbo | 208.00M | 16.20% |
Net na kita | 9.00M | -83.33% |
Net profit margin | 3.02 | -83.61% |
Kita sa bawat share | 0.32 | -25.84% |
EBITDA | 48.00M | -25.00% |
Aktuwal na % ng binabayarang buwis | 70.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 320.00M | -21.95% |
Kabuuang asset | 1.47B | -24.97% |
Kabuuang sagutin | 1.67B | -14.48% |
Kabuuang equity | -205.00M | — |
Natitirang share | 124.90M | — |
Presyo para makapag-book | -4.27 | — |
Return on assets | 6.83% | — |
Return on capital | 69.93% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 9.00M | -83.33% |
Cash mula sa mga operasyon | -20.00M | 92.88% |
Cash mula sa pag-invest | 10.00M | 66.67% |
Cash mula sa financing | 42.00M | 300.00% |
Net change in cash | 31.00M | 110.54% |
Malayang cash flow | -47.75M | 81.67% |
Tungkol
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Itinatag
Set 26, 2014
Website
Mga Empleyado
1,000
